Perceptive Advisors’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

Perceptive Advisors’s Portfolio RVMDW Stock Details RVMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.34M	Hold	250,000	–	–	0.04%	101
2026 Q1	$448K	Hold	250,000	–	–	0.01%	91
2025 Q4	$235K	Hold	250,000	–	–	﹤0.01%	114
2025 Q3	$75K	Hold	250,000	–	–	﹤0.01%	91
2025 Q2	$65.7K	Hold	250,000	–	–	﹤0.01%	84
2025 Q1	$9.5K	Hold	250,000	–	–	﹤0.01%	86
2024 Q4	$45K	Hold	250,000	–	–	﹤0.01%	98
2024 Q3	$35K	Hold	250,000	–	–	﹤0.01%	106
2024 Q2	$25.5K	Hold	250,000	–	–	﹤0.01%	108
2024 Q1	$45.6K	Hold	250,000	–	–	﹤0.01%	110
2023 Q4	$82.5K	Buy	+250,000	New	+$112K	﹤0.01%	98

Other funds holding RVMDW

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Caption Management Oklahoma City, Oklahoma $21.5B AUM 81.81% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Perceptive Advisors's RVMDW Position: Q2 2026 in Review

Perceptive Advisors held its Revolution Medicines Inc Warrant (RVMDW) position steady in Q2 2026 at 250,000 shares worth $2.34M. The position accounts for 0.04% of the portfolio, ranked #101.

Perceptive Advisors first reported a position in RVMDW in Q4 2023 and has held it in 11 quarters since. 22 funds tracked by Wall St. Rank hold RVMDW as of Q2 2026.

Perceptive Advisors held 250,000 shares of Revolution Medicines Inc Warrant worth $2.34M as of Q2 2026.
Perceptive Advisors left its Revolution Medicines Inc Warrant share count unchanged in Q2 2026.
Revolution Medicines Inc Warrant made up 0.04% of Perceptive Advisors's portfolio in Q2 2026, its #101 holding.
Perceptive Advisors first reported a position in Revolution Medicines Inc Warrant in Q4 2023 and has held it in 11 quarters since.
22 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q2 2026.

Based on Perceptive Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.